Roluperidone 64 mg

DRUG2 trials

Sponsors

Minerva Neurosciences

Conditions

Negative Symptoms in SchizophreniaNegative Symptoms of Schizophrenia

Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

CompletedNCT06107803

Minerva NeurosciencesNegative Symptoms in Schizophrenia

Start: 2023-10-13End: 2024-01-12Updated: 2025-03-26

Phase 3

Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia

CompletedNCT03397134

Minerva NeurosciencesNegative Symptoms of Schizophrenia

Start: 2017-12-15End: 2021-02-15Updated: 2023-04-28

Related Papers

Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia

Schizophrenia Bulletin2022-01-2754 citations